James A. Grigsby serves as Executive at CYTOGEN CORP, where they oversee executive responsibilities. Since joining the company, James A. Grigsby has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on May 8, 2008 involved selling 7,000 shares valued at $0.
James A. Grigsby currently holds 10,000 shares of CYTOGEN CORP (CYTO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James A. Grigsby has been a net neutral trader of CYTO stock. They have purchased $0 and sold $0 worth of shares.
James A. Grigsby's most recent insider trade was on May 8, 2008, when they sold 7,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jun 13, 2007 | CYTO | $0 | Award | 10,000 | $N/A | Discretionary |